I know I bang on about it a bit, but a report from Monash Investment Partners estimates IPD net profit of 700m p.a for lymphodeama and congestive heart failure in the US alone. Current MC 500m.
Interesting that it is maintaining its price as Shortman suggests significant short action last week.
The Brains Trust - 2016, page-9971
-
- There are more pages in this discussion • 4,581 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add XSO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3,185.4 |
Change
-28.600(0.89%) |
Mkt cap ! n/a | |||
| Open | High | Low |
| 3,214.0 | 3,214.0 | 3,185.4 |
| XSO (ASX) Chart |